Longwood Fund
3 rounds tracked since 8 April 2026.
- Rounds
- 3
- Led
- 0
- Capital in these rounds
- $362M
Sectors
Countries
Rounds
- Coultreon BiopharmaDevelops therapies advancing an immunology drug pipeline. $125MSeries A · 28 Apr
- NeomorphDevelops molecular glue degraders to address previously undruggable proteins in serious diseases. $100MSeries B · 13 Apr
- Sidewinder TherapeuticsDevelops precision bispecific antibody-drug conjugates for cancer treatment. $137MSeries B · 8 Apr
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise